Publication:
Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients

dc.contributor.authorPorntip Chaichompooen_US
dc.contributor.authorPanida Kumyaen_US
dc.contributor.authorLadawan Khowawisetsuten_US
dc.contributor.authorWararat Chiangjongen_US
dc.contributor.authorSakdithep Chaiyariten_US
dc.contributor.authorNutkridta Pongsakulen_US
dc.contributor.authorNoppadol Sirithanaratanakulen_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.authorVisith Thongboonkerden_US
dc.contributor.authorKovit Pattanapanyasaten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-11T04:32:25Z
dc.date.available2018-06-11T04:32:25Z
dc.date.issued2012-12-05en_US
dc.description.abstractAggregatability and oxidative damage of red blood cells (RBCs), platelet activation and increased amount of blood cells-derived microparticles (MPs) are thought to be the etiologies for the thrombotic risk in thalassemia, but with unclear mechanisms. Here we report cellular origins and increases in number, oxidative stress status, and procoagulant activity, as well as altered proteome of MPs isolated from β-thal/HbE patients. Flow cytometric analysis revealed that β-thal/HbE patients had significantly higher levels of phosphatidylserine (PS)-bearing MPs in platelet-free plasma (PFP) as compared to normal subjects. The high levels of MPs correlated with not only the increased procoagulant activity but also the increased platelet counts. Additionally, these PS-bearing MPs were originated mostly from platelets and RBCs, both of which had increased levels of reactive oxygen species. Proteome analysis of MPs by 2-DE followed by Q-TOF MS and MS/MS analyses identified 29 proteins with significantly altered levels in MPs derived from β-thal/HbE patients (e.g. the increased levels of peroxiredoxin 6, apolipoprotein E, cyclophilin A and heat shock protein 90). These findings suggest that the oxidative damage in platelets and RBCs potentially induces production of MPs with altered proteome that may, in turn, facilitate thromboembolic complications, which are commonly found in thalassemic patients. This article is part of a Special Issue entitled: Integrated omics. © 2012 Elsevier B.V.en_US
dc.identifier.citationJournal of Proteomics. Vol.76, (2012), 239-250en_US
dc.identifier.doi10.1016/j.jprot.2012.06.004en_US
dc.identifier.issn18767737en_US
dc.identifier.issn18743919en_US
dc.identifier.other2-s2.0-84869871106en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/13549
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84869871106&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleCharacterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84869871106&origin=inwarden_US

Files

Collections